Missouri Senate debates SB54 to reclassify hemp-derived intoxicants; amendment to grandfather existing vendors fails

The Missouri Senate spent much of its April 8 session debating Senate Bill 54, a bill that would bring intoxicating cannabinoids derived from hemp under the regulatory framework used for marijuana.

Sponsor arguments focused on public-health data and gaps in federal oversight. "It is a public health crisis," the Senator from the second said, arguing that chemically converted hemp products are sold to minors in convenience stores and lack testing for potency and contaminants. The sponsor cited poison-control and hospitalization trends in arguing for age limits, testing, labeling and licensing similar to the existing marijuana regulatory system.

Opponents countered that the substitute before the chamber would impose an unfair, industry-wide reclassification that largely benefits existing dispensary license holders and risks shutting long-established, USDA-registered hemp manufacturers out of retail channels. "It's creating an unfair business advantage to 1 group over another," the Senator from the fourth said repeatedly, urging a path that regulates — rather than folds — legitimate hemp businesses into the marijuana market.

Lawmakers pressed the sponsor and each other on technical points that repeatedly surfaced: which products the federal Farm Bill actually preempts, whether the U.S. Department of Agriculture or…